Ardelyx | ARDX - Market Capitalization


Ardelyx reported $1.52B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.



Financials
Stock Price USD
Assets USD 466.77M
Cash and Equivalent USD 90.04M
Cost of Sales USD 14.82M
Current Assets USD 351.57M
Current Liabilities USD 81.72M
Debt USD 206.64M
Dividend Yield -6.39
EBIT USD -12.5M
EBITDA USD -11.87M
Employees 395
EPS Earnings Per Share USD -0.08
Equity Capital and Reserves USD 139.53M
Gross Profit on Sales USD 82.84M
Interest Expense on Debt USD 6.58M
Loan Capital USD 229.21M
Market Capitalization USD 1.52B
Net Income USD -19.08M
Operating Expenses USD 112.06M
Operating Profit USD -14.4M
Ordinary Share Capital USD 240.77M
Pre-Tax Profit USD -19.08M
Sales Revenues USD 97.66M
Selling and Administration Expenses USD 83.99M
Stock USD 22.28M
Trade Creditors USD 21.68M
Trade Debtors USD 62.55M

Market Capitalization Change Date
Abbott USD 236.64B 6.58B Jun/2025
Amgen USD 150.13B 17.37B Jun/2025
Ardelyx USD 1.51B 568M Sep/2025
Corcept Therapeutics USD 7.78B 4.27B Jun/2025
Life Technologies USD 365M 357M Sep/2025
Sanofi EUR 125.19B 7.59B Sep/2025
TG Therapeutics USD 5.71B 526M Jun/2025
United Therapeutics USD 12.96B 934M Jun/2025